Cargando…

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

BACKGROUND: CC-chemokine receptor seven (CCR7), a G-protein coupled receptor normally facilitating immune cells lymphatic homing, has recently been identified on several cancer cells in promoting invasion and lymphatic specific metastasis by mimicking normal leukocytes. As tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yu, Liu, Li, Xiong, Ying, Bai, Qi, Wang, Jiajun, Xi, Wei, Qu, Yang, Xu, Jiejie, Guo, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259971/ https://www.ncbi.nlm.nih.gov/pubmed/28114889 http://dx.doi.org/10.1186/s12885-017-3065-3

Ejemplares similares

Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma
por: Liu, Li, et al.
Publicado: (2017)

Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2016)

Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
por: Xi, Wei, et al.
Publicado: (2021)

Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017)

Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2017)

Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis
por: Li, Yuxin, et al.
Publicado: (2021)

Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
por: Xu, Xianglai, et al.
Publicado: (2023)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Study of CC chemokine receptor 5 in renal allograft rejection
por: Ghosh, R., et al.
Publicado: (2013)

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2017)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2015)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
por: Korbecki, Jan, et al.
Publicado: (2020)

Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Qu, Yang, et al.
Publicado: (2016)

The Role of CC-Chemokines in the Regulation of Angiogenesis
por: Ridiandries, Anisyah, et al.
Publicado: (2016)

The roles of CC chemokines in response to radiation
por: Wang, Lei, et al.
Publicado: (2022)

Sialylated O-Glycans and Sulfated Tyrosines in the NH(2)-Terminal Domain of CC Chemokine Receptor 5 Contribute to High Affinity Binding of Chemokines
por: Bannert, Norbert, et al.
Publicado: (2001)

Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021)

Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xi, Wei, et al.
Publicado: (2016)

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis
por: Xu, Yawei, et al.
Publicado: (2019)

Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
por: Scotton, C, et al.
Publicado: (2001)

Prognostic value of spleen tyrosine kinase in human solid tumors
por: Ni, Beibei, et al.
Publicado: (2018)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
por: Liu, Fangteng, et al.
Publicado: (2021)

Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
por: Xu, Xianglai, et al.
Publicado: (2023)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015)

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist
por: Isaikina, Polina, et al.
Publicado: (2021)

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Selected CC and CXC chemokines in children with atopic asthma
por: Machura, Edyta, et al.
Publicado: (2016)

Role of CC-chemokine ligand 2 in gynecological cancer
por: Zhang, Jia-Jia, et al.
Publicado: (2022)

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
por: Sun, Dawei, et al.
Publicado: (2023)

Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Wang, Jiajun, et al.
Publicado: (2017)

Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study
por: Liu, Li, et al.
Publicado: (2013)

Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Yao, Jia-Xi, et al.
Publicado: (2018)

HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma
por: Xu, Xianglai, et al.
Publicado: (2023)

Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
por: Park, Tae Ju, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ull4koouh0vfdok1bk3dfa6ekc